Oracle Associates LLC - Insider Trading Tracker

Abeona Therapeutics Inc.

US ˙ NasdaqCM ˙ US00289Y2063

Pengenalan

Halaman ini menyediakan analisis menyeluruh tentang sejarah dagangan orang dalam yang diketahui Oracle Associates LLC. Orang dalam ialah pegawai, pengarah atau pelabur penting dalam syarikat. Adalah haram bagi orang dalam untuk membuat perdagangan dalam syarikat mereka berdasarkan maklumat khusus bukan awam. Ini tidak bermakna haram bagi mereka untuk membuat sebarang perdagangan dalam syarikat mereka sendiri. Tetapi mereka mesti melaporkan semua perdagangan kepada SEC melalui Borang 4. Walaupun terdapat sekatan ini, penyelidikan akademik menunjukkan bahawa orang dalam - secara amnya - cenderung untuk mengatasi prestasi pasaran dalam syarikat mereka sendiri.

Purata Keuntungan Perdagangan

Purata keuntungan perdagangan ialah purata pulangan semua pembelian pasaran terbuka yang dibuat oleh orang dalam dalam tempoh tiga tahun terakhir. Untuk mengira ini, kami memeriksa setiap pembelian pasaran terbuka yang tidak dirancang oleh orang dalam, tidak termasuk semua dagangan yang ditandakan sebagai sebahagian daripada pelan dagangan 10b5-1. Kami kemudian mengira prestasi purata dagangan tersebut sepanjang 3, 6 dan 12 bulan, dengan purata setiap tempoh tersebut untuk menjana metrik prestasi akhir bagi setiap dagangan. Akhir sekali, kami puratakan semua metrik prestasi untuk mengira metrik prestasi untuk orang dalam. Senarai ini hanya termasuk orang dalam yang telah membuat sekurang-kurangnya tiga dagangan dalam dua tahun lepas.

Jika keuntungan berdagang orang dalam ini ialah "N/A", maka orang dalam sama ada tidak membuat sebarang pembelian pasaran terbuka dalam tempoh tiga tahun terakhir, atau dagangan yang mereka buat adalah terlalu baru untuk mengira metrik prestasi yang boleh dipercayai.

Kekerapan Kemas Kini: Harian

Lihat senarai pedagang dalaman yang paling menguntungkan.

Lihat Orang Dalam Dengan Kedudukan Tertinggi

Syarikat dengan Kedudukan Orang Dalam yang Dilaporkan

Pemfailan SEC menunjukkan Oracle Associates LLC telah melaporkan pegangan atau perdagangan dalam syarikat berikut:

Sekuriti	Tajuk	Pegangan Terkini Dilaporkan
US:SLNO / Soleno Therapeutics, Inc.	10% Owner	4,016,283
US:BIOL / BIOLASE, Inc.	10% Owner	30,866,265
US:VRML / Vermillion, Inc.	10% Owner	0
US:HNSN / Hansen Medical, Inc.	10% Owner	0
US:ACCP /	10% Owner	119,811

Bagaimana Mentafsir Carta

Carta berikut menunjukkan prestasi saham sekuriti selepas setiap dagangan pasaran terbuka dan tidak dirancang yang dibuat oleh Oracle Associates LLC. Perdagangan tidak dirancang ialah dagangan yang tidak dibuat sebagai sebahagian daripada pelan dagangan 10b5-1. Prestasi saham dicatatkan sebagai perubahan peratus kumulatif dalam harga saham. Sebagai contoh, jika perdagangan orang dalam dibuat pada 1 Januari 2019, carta akan menunjukkan perubahan peratusan harian sekuriti kepada hari ini. Jika harga saham naik dari $10 kepada $15 pada masa ini, perubahan peratus terkumpul dalam harga saham ialah 50%. Perubahan dalam harga daripada $10 kepada $20 ialah 100% dan perubahan dalam harga $10 hingga $5 ialah -50%.

Secara dasarnya, kami cuba untuk menentukan sejauh mana dagangan orang dalam berkait rapat dengan pulangan berlebihan (positif atau negatif) dalam harga saham untuk melihat sama ada orang dalam menetapkan masa dagangan mereka untuk mendapat keuntungan daripada maklumat orang dalam. Pertimbangkan situasi di mana orang dalam melakukan perkara ini. Dalam keadaan ini, kami menjangkakan sama ada (a) pulangan positif selepas pembelian, atau (b) pulangan negatif selepas jualan. Dalam kes (a), carta PEMBELIAN akan menunjukkan satu siri keluk condong ke atas, menunjukkan pulangan positif selepas setiap transaksi pembelian. Dalam kes (b), carta JUALAN akan menunjukkan satu siri keluk condong ke bawah, menunjukkan pulangan negatif selepas setiap transaksi jualan.

Walau bagaimanapun, ini sahaja tidak cukup untuk membuat kesimpulan. Jika, sebagai contoh, harga saham syarikat berada dalam pendakian bukan disebabkan kitaran selama bertahun-tahun, maka kami menjangkakan semua plot selepas pembelian akan condong ke atas. Begitu juga, kemerosotan bukan disebabkan kitaran selama bertahun-tahun akan mengakibatkan plot pasca perdagangan condong ke bawah. Kedua-dua carta ini tidak akan mencadangkan aktiviti perdagangan orang dalam.

Penunjuk terkuat ialah keadaan di mana harga saham adalah sangat kitaran, dan terdapat kedua-dua isyarat positif dalam carta PEMBELIAN dan plot negatif pada carta JUALAN. Situasi ini akan sangat menunjukkan orang dalam yang menentukan masa perdagangan untuk kelebihan kewangan mereka.

Pembelian Orang Dalam ABEO / Abeona Therapeutics Inc. - Analisis Keuntungan Jangka Pendek

Dalam bahagian ini, kami menganalisis keuntungan setiap pembelian orang dalam pasaran terbuka yang tidak dirancang yang dibuat dalam ABEO / Abeona Therapeutics Inc.. Analisis ini membantu untuk memahami sama ada orang dalam secara konsisten menjana pulangan tidak normal dan patut diikuti. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah bersifat teori .

Jadual berikut menunjukkan pembelian pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan	Simbol Saham	Orang dalam	Saham Dilaporkan	Harga Dilaporkan	Saham Dilaraskan	Harga Dilaraskan	Asas Kos	Hari ke Maks
2008-02-12	ACCP	FEINBERG LARRY N	29,736	3.1500	29,736	3.1500	93,668	731
2007-06-19	ACCP	FEINBERG LARRY N	60,000	5.1700	60,000	5.1700	310,200
2007-01-22	ACCP	FEINBERG LARRY N	6,040	2.5300	6,040	2.5300	15,281
2005-12-31	ACCP	FEINBERG LARRY N	15,636	0.6500	15,636	0.6500	10,163
2005-12-31	ACCP	FEINBERG LARRY N	82,745	0.6500	82,745	0.6500	53,784
2005-12-31	ACCP	FEINBERG LARRY N	299,056	0.6500	299,056	0.6500	194,386
2005-12-31	ACCP	FEINBERG LARRY N	78,184	0.6500	78,184	0.6500	50,820
2005-02-01	ACCP	FEINBERG LARRY N	30,200	2.6900	30,200	2.6900	81,238

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.

Jualan Orang Dalam ABEO / Abeona Therapeutics Inc. - Analisis Kerugian Jangka Pendek

Dalam bahagian ini, kami menganalisis pengelakan kerugian jangka pendek bagi setiap jualan dalaman pasaran terbuka yang tidak dirancang yang dibuat dalam ABEO / Abeona Therapeutics Inc.. Corak pengelakan kerugian yang konsisten mungkin mencadangkan bahawa urus niaga jualan masa hadapan mungkin meramalkan penurunan harga. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah teori .

Jadual berikut menunjukkan jualan pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan Simbol Saham Orang dalam Saham
Dilaporkan Harga
Dilaporkan Saham
Dilaraskan Harga
Dilaraskan Asas Kos Hari ke
Min Harga pada
Min Kerugian Maks
Dielakkan ($) Kerugian Maks
Dielakkan (%)

2008-02-12 ACCP FEINBERG LARRY N 29,736 3.1500 29,736 3.1500 93,668 731

2007-07-24 ACCP FEINBERG LARRY N 2,040 4.3500 2,040 4.3500 8,874

2007-07-23 ACCP FEINBERG LARRY N 4,000 4.3563 4,000 4.3563 17,425

2007-06-19 ACCP FEINBERG LARRY N 40,000 5.1700 40,000 5.1700 206,800

2007-06-19 ACCP FEINBERG LARRY N 20,000 5.1700 20,000 5.1700 103,400

2007-03-01 ACCP FEINBERG LARRY N 1,200 7.1250 1,200 7.1250 8,550

2007-02-28 ACCP FEINBERG LARRY N 10,000 7.1000 10,000 7.1000 71,000

2007-02-28 ACCP FEINBERG LARRY N 4,500 7.1000 4,500 7.1000 31,950

2007-02-27 ACCP FEINBERG LARRY N 300 7.0000 300 7.0000 2,100

2007-02-27 ACCP FEINBERG LARRY N 100 7.0000 100 7.0000 700

2007-02-26 ACCP FEINBERG LARRY N 19,000 7.3140 19,000 7.3140 138,966

2007-02-26 ACCP FEINBERG LARRY N 5,000 7.3140 5,000 7.3140 36,570

2007-02-26 ACCP FEINBERG LARRY N 1,000 7.3140 1,000 7.3140 7,314

2007-01-22 ACCP FEINBERG LARRY N 6,040 2.5300 6,040 2.5300 15,281

2006-09-01 ACCP FEINBERG LARRY N 1 1

2006-09-01 ACCP FEINBERG LARRY N 0 0

2006-09-01 ACCP FEINBERG LARRY N 0 0

2005-02-01 ACCP FEINBERG LARRY N 30,200 2.6900 30,200 2.6900 81,238

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.

Pembelian Orang Dalam AWHL / Aspira Women's Health Inc. - Analisis Keuntungan Jangka Pendek

Dalam bahagian ini, kami menganalisis keuntungan setiap pembelian orang dalam pasaran terbuka yang tidak dirancang yang dibuat dalam ABEO / Abeona Therapeutics Inc.. Analisis ini membantu untuk memahami sama ada orang dalam secara konsisten menjana pulangan tidak normal dan patut diikuti. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah bersifat teori .

Jadual berikut menunjukkan pembelian pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan Simbol Saham Orang dalam Saham
Dilaporkan Harga
Dilaporkan Saham
Dilaraskan Harga
Dilaraskan Asas Kos Hari ke
Maks Harga pada
Maks Maks
Keuntungan ($) Pulangan Maks (%)

2017-02-17 VRML FEINBERG LARRY N 617,731 1.4000 617,731 1.4000 864,823 304

2015-07-14 VRML FEINBERG LARRY N 510,204 1.9600 510,204 1.9600 1,000,000

2015-07-14 VRML FEINBERG LARRY N 1,839 1.9054 1,839 1.9054 3,504

2014-12-23 VRML FEINBERG LARRY N 972,222 1.4400 972,222 1.4400 1,400,000

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.

Jualan Orang Dalam AWHL / Aspira Women's Health Inc. - Analisis Kerugian Jangka Pendek

Dalam bahagian ini, kami menganalisis pengelakan kerugian jangka pendek bagi setiap jualan dalaman pasaran terbuka yang tidak dirancang yang dibuat dalam ABEO / Abeona Therapeutics Inc.. Corak pengelakan kerugian yang konsisten mungkin mencadangkan bahawa urus niaga jualan masa hadapan mungkin meramalkan penurunan harga. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah teori .

Jadual berikut menunjukkan jualan pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan Simbol Saham Orang dalam Saham
Dilaporkan Harga
Dilaporkan Saham
Dilaraskan Harga
Dilaraskan Asas Kos Hari ke
Min Harga pada
Min Kerugian Maks
Dielakkan ($) Kerugian Maks
Dielakkan (%)

Tiada dagangan pasaran terbuka tidak dirancang yang tidak diketahui untuk gabungan orang dalam dan sekuriti ini

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.

Pembelian Orang Dalam SLNO / Soleno Therapeutics, Inc. - Analisis Keuntungan Jangka Pendek

Dalam bahagian ini, kami menganalisis keuntungan setiap pembelian orang dalam pasaran terbuka yang tidak dirancang yang dibuat dalam ABEO / Abeona Therapeutics Inc.. Analisis ini membantu untuk memahami sama ada orang dalam secara konsisten menjana pulangan tidak normal dan patut diikuti. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah bersifat teori .

Jadual berikut menunjukkan pembelian pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan Simbol Saham Orang dalam Saham
Dilaporkan Harga
Dilaporkan Saham
Dilaraskan Harga
Dilaraskan Asas Kos Hari ke
Maks Harga pada
Maks Maks
Keuntungan ($) Pulangan Maks (%)

Tiada dagangan pasaran terbuka tidak dirancang yang tidak diketahui untuk gabungan orang dalam dan sekuriti ini

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.

Jualan Orang Dalam SLNO / Soleno Therapeutics, Inc. - Analisis Kerugian Jangka Pendek

Dalam bahagian ini, kami menganalisis pengelakan kerugian jangka pendek bagi setiap jualan dalaman pasaran terbuka yang tidak dirancang yang dibuat dalam ABEO / Abeona Therapeutics Inc.. Corak pengelakan kerugian yang konsisten mungkin mencadangkan bahawa urus niaga jualan masa hadapan mungkin meramalkan penurunan harga. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah teori .

Jadual berikut menunjukkan jualan pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan Simbol Saham Orang dalam Saham
Dilaporkan Harga
Dilaporkan Saham
Dilaraskan Harga
Dilaraskan Asas Kos Hari ke
Min Harga pada
Min Kerugian Maks
Dielakkan ($) Kerugian Maks
Dielakkan (%)

Tiada dagangan pasaran terbuka tidak dirancang yang tidak diketahui untuk gabungan orang dalam dan sekuriti ini

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.

Sejarah Dagangan Orang Dalam

Jadual ini menunjukkan senarai lengkap dagangan orang dalam yang dibuat oleh Oracle Associates LLC seperti yang didedahkan kepada Suruhanjaya Bursa Sekuriti (SEC).

Tarikh Fail Tarikh Tran Borang Simbol Saham Sekuriti Kod 10b5-1 Saham Baki Saham Peratus
Ubah Saham
harga Tran
Nilai Baki
Nilai

2017-12-26 3 SLNO SOLENO THERAPEUTICS INC
Common Stock, par value $0.001 per share 4,016,283

2017-12-26 3 SLNO SOLENO THERAPEUTICS INC
Common Stock, par value $0.001 per share 2,605,156

2017-12-26 3 SLNO SOLENO THERAPEUTICS INC
Common Stock, par value $0.001 per share 2,930,801

2017-12-26 3 SLNO SOLENO THERAPEUTICS INC
Common Stock, par value $0.001 per share 4,016,283

2017-12-26 3 SLNO SOLENO THERAPEUTICS INC
Common Stock, par value $0.001 per share 2,605,156

2017-12-26 3 SLNO SOLENO THERAPEUTICS INC
Common Stock, par value $0.001 per share 2,930,801

2017-12-26 3 SLNO SOLENO THERAPEUTICS INC
Common Stock, par value $0.001 per share 4,016,283

2017-12-26 3 SLNO SOLENO THERAPEUTICS INC
Common Stock, par value $0.001 per share 2,605,156

2017-12-26 3 SLNO SOLENO THERAPEUTICS INC
Common Stock, par value $0.001 per share 2,930,801

2017-12-26 3 SLNO SOLENO THERAPEUTICS INC
Common Stock, par value $0.001 per share 4,016,283

2017-12-26 3 SLNO SOLENO THERAPEUTICS INC
Common Stock, par value $0.001 per share 2,605,156

2017-12-26 3 SLNO SOLENO THERAPEUTICS INC
Common Stock, par value $0.001 per share 2,930,801

2017-12-26 3 SLNO SOLENO THERAPEUTICS INC
Common Stock, par value $0.001 per share 4,016,283

2017-12-26 3 SLNO SOLENO THERAPEUTICS INC
Common Stock, par value $0.001 per share 2,605,156

2017-12-26 3 SLNO SOLENO THERAPEUTICS INC
Common Stock, par value $0.001 per share 2,930,801

2017-12-06 2017-12-05 4 BIOL BIOLASE, INC
Common Stock P - Purchase 10,745,615 30,866,265 53.41 0.46 4,900,000 14,075,017

2017-12-06 2017-12-04 4 BIOL BIOLASE, INC
Common Stock P - Purchase 1,800,000 20,120,650 9.82 0.30 540,000 6,036,195

2017-08-31 2017-08-31 4 VRML VERMILLION, INC.
Warrants to acquire Common Stock X - Other -583,333 0 -100.00

2017-08-31 2017-08-31 4 VRML VERMILLION, INC.
Common Stock X - Other 583,333 9,825,289 6.31 1.00 583,333 9,825,289

2017-08-30 2017-08-25 4 VRML VERMILLION, INC.
Warrants to acquire Common Stock P - Purchase 583,333 583,333

2017-08-30 2017-08-25 4 VRML VERMILLION, INC.
Warrants to acquire Common Stock H - Other -583,333 0 -100.00

2017-07-05 2017-06-30 4 BIOL BIOLASE, INC
Warrants to acquire Common Stock P - Purchase 1,800,535 3,144,811 133.94 0.12 225,067 393,101

2017-07-05 2017-06-30 4 BIOL BIOLASE, INC
Series D Preferred Stock C - Conversion -36,986 0 -100.00

2017-07-05 2017-06-30 4 BIOL BIOLASE, INC
Common Stock C - Conversion 3,698,600 18,320,650 25.29 1.24 4,586,264 22,717,606

2017-02-17 2017-02-17 4 VRML VERMILLION, INC.
Warrant to acquire Common Stock P - Purchase 1 0 -100.00

2017-02-17 2017-02-17 4 VRML VERMILLION, INC.
Common Stock, par value $0.001 per share P - Purchase 617,731 9,825,289 6.71 1.40 864,823 13,755,405

2016-12-06 2016-12-05 4 BIOL BIOLASE, INC
Common Stock C - Conversion 46,463 14,608,464 0.32 1.85 85,957 27,025,658

2016-12-06 2016-12-02 4 BIOL BIOLASE, INC
Common Stock C - Conversion 53,537 14,562,001 0.37 1.78 95,296 25,920,362

2016-11-17 2016-11-16 4 BIOL BIOLASE, INC
Common Stock C - Conversion 33,674 14,508,464 0.23 1.71 57,583 24,809,473

2016-11-17 2016-11-15 4 BIOL BIOLASE, INC
Common Stock C - Conversion 18,514 14,478,326 0.13 1.72 31,844 24,902,721

2016-11-14 2016-11-14 4 BIOL BIOLASE, INC
Common Stock C - Conversion 33,674 14,459,812 0.23 1.61 54,215 23,280,297

2016-11-14 2016-11-11 4 BIOL BIOLASE, INC
Common Stock C - Conversion 48,513 14,426,138 0.34 1.81 87,809 26,111,310

2016-11-14 2016-11-10 4 BIOL BIOLASE, INC
Common Stock C - Conversion 42,000 14,377,625 0.29 1.81 76,020 26,023,501

2016-11-10 2016-11-09 4 BIOL BIOLASE, INC
Common Stock C - Conversion 125,000 14,335,625 0.88 1.70 212,500 24,370,562

2016-11-10 2016-11-08 4 BIOL BIOLASE, INC
Common Stock C - Conversion 2,000 14,230,625 0.01 1.52 3,040 21,630,550

2016-10-05 2016-09-30 4 BIOL BIOLASE, INC
Warrants to acquire Common Stock P - Purchase 850,797 2,194,983 63.29

2016-10-05 2016-09-30 4 BIOL BIOLASE, INC
Series C Preferred Stock C - Conversion -37,091 0 -100.00

2016-10-05 2016-09-30 4 BIOL BIOLASE, INC
Common Stock C - Conversion 3,699,100 14,228,625 35.13 1.13 4,179,983 16,078,346

2016-08-10 2016-08-08 4 BIOL BIOLASE, INC
Series C Preferred Stock P - Purchase 37,091 37,091 1.13 41,913 41,913

2016-08-10 2016-08-08 4 BIOL BIOLASE, INC
Warrants to acquire Common Stock P - Purchase 850,797 2,194,983 63.29 0.12 106,350 274,373

2016-07-29 2016-07-27 4 HNSN HANSEN MEDICAL INC
Common Stock, par value $0.0001 per share D - Sale to Issuer -22,659 0 -100.00 90,636.00 -2,053,721,124

2016-07-29 2016-07-27 4 HNSN HANSEN MEDICAL INC
Common Stock, par value $0.0001 per share D - Sale to Issuer -19,050 0 -100.00 76,200.00 -1,451,610,000

2016-07-29 2016-07-27 4 HNSN HANSEN MEDICAL INC
Common Stock, par value $0.0001 per share D - Sale to Issuer -3,950 0 -100.00 15,800.00 -62,410,000

2016-07-29 2016-07-27 4 HNSN HANSEN MEDICAL INC
Common Stock, par value $0.0001 per share D - Sale to Issuer -492,846 0 -100.00 1,971,384.00 -971,588,718,864

2016-07-29 2016-07-27 4 HNSN HANSEN MEDICAL INC
Common Stock, par value $0.0001 per share D - Sale to Issuer -854,377 0 -100.00 3,417,508.00 -2,919,840,232,516

2016-07-29 2016-07-27 4 HNSN HANSEN MEDICAL INC
Common Stock, par value $0.0001 per share D - Sale to Issuer -3,090,732 0 -100.00 12,362,928.00 -38,210,497,183,296

2015-07-16 2015-07-14 4 VRML VERMILLION, INC.
Common Stock, par value $0.001 per share P - Purchase 1,839 8,624,225 0.02 1.91 3,504 16,432,598

2015-07-16 2015-07-14 4 VRML VERMILLION, INC.
Common Stock, par value $0.001 per share P - Purchase 510,204 8,624,225 6.29 1.96 1,000,000 16,903,481

2015-05-14 2015-05-12 4 HNSN HANSEN MEDICAL INC
Series E Warrant J - Other 2,308,000 2,308,000

2015-05-14 2015-05-12 4 HNSN HANSEN MEDICAL INC
Series E Warrant J - Other 3,846,000 3,846,000

2015-05-14 2015-05-12 4 HNSN HANSEN MEDICAL INC
Series E Warrant J - Other 12,308,000 12,308,000

2015-05-14 2015-05-12 4 HNSN HANSEN MEDICAL INC
Common Stock, par value $0.0001 per share P - Purchase 2,361,342 4,928,288 91.99 0.65 1,534,872 3,203,387

2015-05-14 2015-05-12 4 HNSN HANSEN MEDICAL INC
Common Stock, par value $0.0001 per share P - Purchase 3,934,886 8,543,465 85.38 0.65 2,557,676 5,553,252

2015-05-14 2015-05-12 4 HNSN HANSEN MEDICAL INC
Common Stock, par value $0.0001 per share P - Purchase 12,592,453 30,906,311 68.76 0.65 8,185,094 20,089,102

2014-12-29 2014-12-23 4 VRML VERMILLION, INC.
Warrants to acquire Common Stock P - Purchase 583,333 0 -100.00

2014-12-29 2014-12-23 4 VRML VERMILLION, INC.
Common Stock, Par Value $0.001 per share P - Purchase 972,222 8,112,182 13.62 1.44 1,400,000 11,681,542

2014-08-25 2014-08-25 4 HNSN HANSEN MEDICAL INC
Series B/C Exchange Warrant X - Other -652,724 0 -100.00

2014-08-25 2014-08-25 4 HNSN HANSEN MEDICAL INC
Series B/C Exchange Warrant X - Other -1,171,866 0 -100.00

2014-08-25 2014-08-25 4 HNSN HANSEN MEDICAL INC
Series B/C Exchange Warrant X - Other -4,656,852 0 -100.00

2014-08-25 2014-08-25 4 HNSN HANSEN MEDICAL INC
Common Stock, par value $0.0001 per share X - Other 652,724 2,566,946 34.10 1.13 737,578 2,900,649

2014-08-25 2014-08-25 4 HNSN HANSEN MEDICAL INC
Common Stock, par value $0.0001 per share X - Other 1,171,866 4,608,579 34.10 1.13 1,324,209 5,207,694

2014-08-25 2014-08-25 4 HNSN HANSEN MEDICAL INC
Common Stock, par value $0.0001 per share X - Other 4,656,852 18,313,858 34.10 1.13 5,262,243 20,694,660

2014-08-12 2014-08-11 4 HNSN HANSEN MEDICAL INC
Series D Warrant J - Other 200,712 200,712

2014-08-12 2014-08-11 4 HNSN HANSEN MEDICAL INC
Series D Warrant J - Other 360,350 360,350

2014-08-12 2014-08-11 4 HNSN HANSEN MEDICAL INC
Series D Warrant J - Other 1,431,983 1,431,983

2014-08-12 2014-08-11 4 HNSN HANSEN MEDICAL INC
Series B/C Exchange Warrant J - Other 652,724 652,724

2014-08-12 2014-08-11 4 HNSN HANSEN MEDICAL INC
Series B/C Exchange Warrant J - Other 1,171,866 1,171,866

2014-08-12 2014-08-11 4 HNSN HANSEN MEDICAL INC
Series B/C Exchange Warrant J - Other 4,656,852 4,656,852

2014-08-12 2014-08-11 4 HNSN HANSEN MEDICAL INC
Series B Warrant J - Other -326,362 0 -100.00

2014-08-12 2014-08-11 4 HNSN HANSEN MEDICAL INC
Series C Warrant J - Other -326,362 0 -100.00

2014-08-12 2014-08-11 4 HNSN HANSEN MEDICAL INC
Series B Warrant J - Other -585,933 0 -100.00

2014-08-12 2014-08-11 4 HNSN HANSEN MEDICAL INC
Series C Warrant J - Other -585,933 0 -100.00

2014-08-12 2014-08-11 4 HNSN HANSEN MEDICAL INC
Series B Warrant J - Other -2,382,426 0 -100.00

2014-08-12 2014-08-11 4 HNSN HANSEN MEDICAL INC
Series C Warrant J - Other -2,382,426 0 -100.00

2014-02-18 2014-02-14 4 HNSN HANSEN MEDICAL INC
Series A Warrant X - Other -326,362 0 -100.00

2014-02-18 2014-02-14 4 HNSN HANSEN MEDICAL INC
Series A Warrant X - Other -585,933 0 -100.00

2014-02-18 2014-02-14 4 HNSN HANSEN MEDICAL INC
Series A Warrant X - Other -2,328,426 0 -100.00

2014-02-18 2014-02-14 4 HNSN HANSEN MEDICAL INC
Common Stock, par value $0.0001 per share X - Other 326,362 1,914,222 20.55 1.23 401,425 2,354,493

2014-02-18 2014-02-14 4 HNSN HANSEN MEDICAL INC
Common Stock, par value $0.0001 per share X - Other 585,933 3,436,713 20.55 1.23 720,698 4,227,157

2014-02-18 2014-02-14 4 HNSN HANSEN MEDICAL INC
Common Stock, par value $0.0001 per share X - Other 2,328,426 13,657,006 20.55 1.23 2,863,964 16,798,117

2013-12-23 2013-12-19 4 VRML VERMILLION, INC.
Warrants to acquire Common Stock C - Conversion -4,339,980 0 -100.00

2013-12-23 2013-12-19 4 VRML VERMILLION, INC.
Common Stock, par value $0.001 per share C - Conversion 4,339,980 7,139,960 155.00

2013-08-08 2013-08-08 4 HNSN HANSEN MEDICAL INC
Series A Warrant P - Purchase 326,362 326,362 0.12 40,795 40,795

2013-08-08 2013-08-08 4 HNSN HANSEN MEDICAL INC
Series C Warrant P - Purchase 326,362 326,362 0.12 40,795 40,795

2013-08-08 2013-08-08 4 HNSN HANSEN MEDICAL INC
Series A Warrant P - Purchase 585,933 585,933 0.12 73,242 73,242

2013-08-08 2013-08-08 4 HNSN HANSEN MEDICAL INC
Series C Warrant P - Purchase 585,933 585,933 0.12 73,242 73,242

2013-08-08 2013-08-08 4 HNSN HANSEN MEDICAL INC
Series A Warrant P - Purchase 2,328,426 2,328,426 0.12 291,053 291,053

2013-08-08 2013-08-08 4 HNSN HANSEN MEDICAL INC
Series C Warrant P - Purchase 2,328,426 2,328,426 0.12 291,053 291,053

2013-08-08 2013-08-08 4 HNSN HANSEN MEDICAL INC
Series B Warrant P - Purchase 326,362 326,362 0.12 40,795 40,795

2013-08-08 2013-08-08 4 HNSN HANSEN MEDICAL INC
Series B Warrant P - Purchase 585,933 585,933 0.12 73,242 73,242

2013-08-08 2013-08-08 4 HNSN HANSEN MEDICAL INC
Series B Warrant P - Purchase 2,328,426 2,328,426 0.12 291,053 291,053

2013-08-08 2013-08-08 4 HNSN HANSEN MEDICAL INC
Common Stock, par value$0.0001 per share P - Purchase 815,904 1,587,860 105.69 1.23 1,003,562 1,953,068

2013-08-08 2013-08-08 4 HNSN HANSEN MEDICAL INC
Common Stock, par value$0.0001 per share P - Purchase 1,464,842 2,850,780 105.69 1.23 1,801,756 3,506,459

2013-08-08 2013-08-08 4 HNSN HANSEN MEDICAL INC
Common Stock, par value$0.0001 per share P - Purchase 5,821,064 11,328,580 105.69 1.23 7,159,909 13,934,153

2013-05-23 3 VRML VERMILLION, INC.
Common Stock, par value $0.001 2,799,980

2008-06-10 2008-03-11 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock Purchase Warrants S - Sale 119,811 119,811

2008-06-10 2008-03-11 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock Purchase Warrants P - Purchase 119,811 119,811

2008-06-10 2008-03-11 4 ACCP ACCESS PHARMACEUTICALS INC
Series A Cumulative Convertible Preferred Stock S - Sale 72 72

2008-06-10 2008-03-11 4 ACCP ACCESS PHARMACEUTICALS INC
Series A Cumulative Convertible Preferred Stock P - Purchase 72 72

2008-06-10 2008-02-12 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock S - Sale -29,736 296,483 -9.12 3.15 -93,668 933,921

2008-06-10 2008-02-12 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock P - Purchase 29,736 296,483 11.15 3.15 93,668 933,921

2008-06-10 2007-11-10 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock Purchase Warrants J - Other 728,850 728,850

2008-06-10 2007-11-10 4 ACCP ACCESS PHARMACEUTICALS INC
Series A Cumulative Convertible Preferred Stock J - Other 437 437

2008-06-10 2007-07-24 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock S - Sale -2,040 296,483 -0.68 4.35 -8,874 1,289,701

2008-06-10 2007-07-23 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock S - Sale -4,000 298,523 -1.32 4.36 -17,425 1,300,456

2008-06-10 2007-06-19 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock P - Purchase 60,000 302,523 24.74 5.17 310,200 1,564,044

2008-06-10 2007-06-19 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock S - Sale -20,000 302,523 -6.20 5.17 -103,400 1,564,044

2008-06-10 2007-06-19 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock S - Sale -40,000 302,523 -11.68 5.17 -206,800 1,564,044

2008-06-10 2007-03-01 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock S - Sale -1,200 302,523 -0.40 7.12 -8,550 2,155,476

2008-06-10 2007-02-28 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock S - Sale -4,500 302,523 -1.47 7.10 -31,950 2,147,913

2008-06-10 2007-02-28 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock S - Sale -10,000 302,523 -3.20 7.10 -71,000 2,147,913

2008-06-10 2007-02-27 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock S - Sale -100 318,223 -0.03 7.00 -700 2,227,561

2008-06-10 2007-02-27 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock S - Sale -300 318,223 -0.09 7.00 -2,100 2,227,561

2008-06-10 2007-02-26 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock S - Sale -1,000 318,623 -0.31 7.31 -7,314 2,330,409

2008-06-10 2007-02-26 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock S - Sale -5,000 318,623 -1.55 7.31 -36,570 2,330,409

2008-06-10 2007-02-26 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock S - Sale -19,000 318,623 -5.63 7.31 -138,966 2,330,409

2008-06-10 2007-01-22 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock P - Purchase 6,040 343,623 1.79 2.53 15,281 869,366

2008-06-10 2007-01-22 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock S - Sale -6,040 343,623 -1.73 2.53 -15,281 869,366

2008-06-10 2006-09-01 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock S - Sale -0 343,623 0.00

2008-06-10 2006-09-01 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock S - Sale -0 343,623 0.00

2008-06-10 2006-09-01 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock S - Sale -1 343,623 0.00

2008-06-10 2006-06-05 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock J - Other -1,374,497 343,624 -80.00

2008-06-10 2005-12-31 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock P - Purchase 78,184 1,718,121 4.77 0.65 50,820 1,116,779

2008-06-10 2005-12-31 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock P - Purchase 299,056 1,718,121 21.07 0.65 194,386 1,116,779

2008-06-10 2005-12-31 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock P - Purchase 82,745 1,718,121 5.06 0.65 53,784 1,116,779

2008-06-10 2005-12-31 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock P - Purchase 15,636 1,718,121 0.92 0.65 10,163 1,116,779

2008-06-10 2005-02-01 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock S - Sale -30,200 1,242,500 -2.37 2.69 -81,238 3,342,325

2008-06-10 2005-02-01 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock, par value $0.01 per share ("Common Stock") P - Purchase 30,200 1,242,500 2.49 2.69 81,238 3,342,325

2008-06-10 3 ACCP ACCESS PHARMACEUTICALS INC
Common Stock, par value $0.01 per share ("Common Stock") 900,400

P

Pasaran terbuka atau pembelian persendirian sekuriti bukan derivatif atau derivatif

S

Pasaran terbuka atau jualan persendirian sekuriti bukan derivatif atau derivatif

A

Pemberian, penganugerahan atau pemerolehan lain sekuriti daripada syarikat (seperti opsyen)

C

Penukaran derivatif

D

Penjualan atau pemindahan sekuriti kembali kepada syarikat

F

Pembayaran harga pelaksanaan atau liabiliti cukai menggunakan sebahagian daripada sekuriti yang diterima daripada syarikat

G

Hadiah sekuriti oleh atau kepada orang dalam

K

Swap ekuiti dan urus niaga lindung nilai yang serupa

M

Pelaksanaan atau penukaran sekuriti derivatif yang diterima daripada syarikat (seperti opsyen)

V

Transaksi dilaporkan secara sukarela pada Borang 4

J

Lain-lain (disertai dengan nota kaki yang menerangkan transaksi)

Tarikh Dagangan	Simbol Saham	Orang dalam	Saham Dilaporkan	Harga Dilaporkan	Saham Dilaraskan	Harga Dilaraskan	Asas Kos	Hari ke Maks
2017-02-17	VRML	FEINBERG LARRY N	617,731	1.4000	617,731	1.4000	864,823	304
2015-07-14	VRML	FEINBERG LARRY N	510,204	1.9600	510,204	1.9600	1,000,000
2015-07-14	VRML	FEINBERG LARRY N	1,839	1.9054	1,839	1.9054	3,504
2014-12-23	VRML	FEINBERG LARRY N	972,222	1.4400	972,222	1.4400	1,400,000

Tarikh Fail	Tarikh Tran	Borang	Simbol Saham	Sekuriti	Kod	Saham	Baki Saham	Peratus Ubah	Saham harga	Tran Nilai	Baki Nilai
2017-12-26		3	SLNO	SOLENO THERAPEUTICS INC Common Stock, par value $0.001 per share			4,016,283
2017-12-26		3	SLNO	SOLENO THERAPEUTICS INC Common Stock, par value $0.001 per share			2,605,156
2017-12-26		3	SLNO	SOLENO THERAPEUTICS INC Common Stock, par value $0.001 per share			2,930,801
2017-12-26		3	SLNO	SOLENO THERAPEUTICS INC Common Stock, par value $0.001 per share			4,016,283
2017-12-26		3	SLNO	SOLENO THERAPEUTICS INC Common Stock, par value $0.001 per share			2,605,156
2017-12-26		3	SLNO	SOLENO THERAPEUTICS INC Common Stock, par value $0.001 per share			2,930,801
2017-12-26		3	SLNO	SOLENO THERAPEUTICS INC Common Stock, par value $0.001 per share			4,016,283
2017-12-26		3	SLNO	SOLENO THERAPEUTICS INC Common Stock, par value $0.001 per share			2,605,156
2017-12-26		3	SLNO	SOLENO THERAPEUTICS INC Common Stock, par value $0.001 per share			2,930,801
2017-12-26		3	SLNO	SOLENO THERAPEUTICS INC Common Stock, par value $0.001 per share			4,016,283
2017-12-26		3	SLNO	SOLENO THERAPEUTICS INC Common Stock, par value $0.001 per share			2,605,156
2017-12-26		3	SLNO	SOLENO THERAPEUTICS INC Common Stock, par value $0.001 per share			2,930,801
2017-12-26		3	SLNO	SOLENO THERAPEUTICS INC Common Stock, par value $0.001 per share			4,016,283
2017-12-26		3	SLNO	SOLENO THERAPEUTICS INC Common Stock, par value $0.001 per share			2,605,156
2017-12-26		3	SLNO	SOLENO THERAPEUTICS INC Common Stock, par value $0.001 per share			2,930,801
2017-12-06	2017-12-05	4	BIOL	BIOLASE, INC Common Stock	P - Purchase	10,745,615	30,866,265	53.41	0.46	4,900,000	14,075,017
2017-12-06	2017-12-04	4	BIOL	BIOLASE, INC Common Stock	P - Purchase	1,800,000	20,120,650	9.82	0.30	540,000	6,036,195
2017-08-31	2017-08-31	4	VRML	VERMILLION, INC. Warrants to acquire Common Stock	X - Other	-583,333	0	-100.00
2017-08-31	2017-08-31	4	VRML	VERMILLION, INC. Common Stock	X - Other	583,333	9,825,289	6.31	1.00	583,333	9,825,289
2017-08-30	2017-08-25	4	VRML	VERMILLION, INC. Warrants to acquire Common Stock	P - Purchase	583,333	583,333
2017-08-30	2017-08-25	4	VRML	VERMILLION, INC. Warrants to acquire Common Stock	H - Other	-583,333	0	-100.00
2017-07-05	2017-06-30	4	BIOL	BIOLASE, INC Warrants to acquire Common Stock	P - Purchase	1,800,535	3,144,811	133.94	0.12	225,067	393,101
2017-07-05	2017-06-30	4	BIOL	BIOLASE, INC Series D Preferred Stock	C - Conversion	-36,986	0	-100.00
2017-07-05	2017-06-30	4	BIOL	BIOLASE, INC Common Stock	C - Conversion	3,698,600	18,320,650	25.29	1.24	4,586,264	22,717,606
2017-02-17	2017-02-17	4	VRML	VERMILLION, INC. Warrant to acquire Common Stock	P - Purchase	1	0	-100.00
2017-02-17	2017-02-17	4	VRML	VERMILLION, INC. Common Stock, par value $0.001 per share	P - Purchase	617,731	9,825,289	6.71	1.40	864,823	13,755,405
2016-12-06	2016-12-05	4	BIOL	BIOLASE, INC Common Stock	C - Conversion	46,463	14,608,464	0.32	1.85	85,957	27,025,658
2016-12-06	2016-12-02	4	BIOL	BIOLASE, INC Common Stock	C - Conversion	53,537	14,562,001	0.37	1.78	95,296	25,920,362
2016-11-17	2016-11-16	4	BIOL	BIOLASE, INC Common Stock	C - Conversion	33,674	14,508,464	0.23	1.71	57,583	24,809,473
2016-11-17	2016-11-15	4	BIOL	BIOLASE, INC Common Stock	C - Conversion	18,514	14,478,326	0.13	1.72	31,844	24,902,721
2016-11-14	2016-11-14	4	BIOL	BIOLASE, INC Common Stock	C - Conversion	33,674	14,459,812	0.23	1.61	54,215	23,280,297
2016-11-14	2016-11-11	4	BIOL	BIOLASE, INC Common Stock	C - Conversion	48,513	14,426,138	0.34	1.81	87,809	26,111,310
2016-11-14	2016-11-10	4	BIOL	BIOLASE, INC Common Stock	C - Conversion	42,000	14,377,625	0.29	1.81	76,020	26,023,501
2016-11-10	2016-11-09	4	BIOL	BIOLASE, INC Common Stock	C - Conversion	125,000	14,335,625	0.88	1.70	212,500	24,370,562
2016-11-10	2016-11-08	4	BIOL	BIOLASE, INC Common Stock	C - Conversion	2,000	14,230,625	0.01	1.52	3,040	21,630,550
2016-10-05	2016-09-30	4	BIOL	BIOLASE, INC Warrants to acquire Common Stock	P - Purchase	850,797	2,194,983	63.29
2016-10-05	2016-09-30	4	BIOL	BIOLASE, INC Series C Preferred Stock	C - Conversion	-37,091	0	-100.00
2016-10-05	2016-09-30	4	BIOL	BIOLASE, INC Common Stock	C - Conversion	3,699,100	14,228,625	35.13	1.13	4,179,983	16,078,346
2016-08-10	2016-08-08	4	BIOL	BIOLASE, INC Series C Preferred Stock	P - Purchase	37,091	37,091		1.13	41,913	41,913
2016-08-10	2016-08-08	4	BIOL	BIOLASE, INC Warrants to acquire Common Stock	P - Purchase	850,797	2,194,983	63.29	0.12	106,350	274,373
2016-07-29	2016-07-27	4	HNSN	HANSEN MEDICAL INC Common Stock, par value $0.0001 per share	D - Sale to Issuer	-22,659	0	-100.00	90,636.00	-2,053,721,124
2016-07-29	2016-07-27	4	HNSN	HANSEN MEDICAL INC Common Stock, par value $0.0001 per share	D - Sale to Issuer	-19,050	0	-100.00	76,200.00	-1,451,610,000
2016-07-29	2016-07-27	4	HNSN	HANSEN MEDICAL INC Common Stock, par value $0.0001 per share	D - Sale to Issuer	-3,950	0	-100.00	15,800.00	-62,410,000
2016-07-29	2016-07-27	4	HNSN	HANSEN MEDICAL INC Common Stock, par value $0.0001 per share	D - Sale to Issuer	-492,846	0	-100.00	1,971,384.00	-971,588,718,864
2016-07-29	2016-07-27	4	HNSN	HANSEN MEDICAL INC Common Stock, par value $0.0001 per share	D - Sale to Issuer	-854,377	0	-100.00	3,417,508.00	-2,919,840,232,516
2016-07-29	2016-07-27	4	HNSN	HANSEN MEDICAL INC Common Stock, par value $0.0001 per share	D - Sale to Issuer	-3,090,732	0	-100.00	12,362,928.00	-38,210,497,183,296
2015-07-16	2015-07-14	4	VRML	VERMILLION, INC. Common Stock, par value $0.001 per share	P - Purchase	1,839	8,624,225	0.02	1.91	3,504	16,432,598
2015-07-16	2015-07-14	4	VRML	VERMILLION, INC. Common Stock, par value $0.001 per share	P - Purchase	510,204	8,624,225	6.29	1.96	1,000,000	16,903,481
2015-05-14	2015-05-12	4	HNSN	HANSEN MEDICAL INC Series E Warrant	J - Other	2,308,000	2,308,000
2015-05-14	2015-05-12	4	HNSN	HANSEN MEDICAL INC Series E Warrant	J - Other	3,846,000	3,846,000
2015-05-14	2015-05-12	4	HNSN	HANSEN MEDICAL INC Series E Warrant	J - Other	12,308,000	12,308,000
2015-05-14	2015-05-12	4	HNSN	HANSEN MEDICAL INC Common Stock, par value $0.0001 per share	P - Purchase	2,361,342	4,928,288	91.99	0.65	1,534,872	3,203,387
2015-05-14	2015-05-12	4	HNSN	HANSEN MEDICAL INC Common Stock, par value $0.0001 per share	P - Purchase	3,934,886	8,543,465	85.38	0.65	2,557,676	5,553,252
2015-05-14	2015-05-12	4	HNSN	HANSEN MEDICAL INC Common Stock, par value $0.0001 per share	P - Purchase	12,592,453	30,906,311	68.76	0.65	8,185,094	20,089,102
2014-12-29	2014-12-23	4	VRML	VERMILLION, INC. Warrants to acquire Common Stock	P - Purchase	583,333	0	-100.00
2014-12-29	2014-12-23	4	VRML	VERMILLION, INC. Common Stock, Par Value $0.001 per share	P - Purchase	972,222	8,112,182	13.62	1.44	1,400,000	11,681,542
2014-08-25	2014-08-25	4	HNSN	HANSEN MEDICAL INC Series B/C Exchange Warrant	X - Other	-652,724	0	-100.00
2014-08-25	2014-08-25	4	HNSN	HANSEN MEDICAL INC Series B/C Exchange Warrant	X - Other	-1,171,866	0	-100.00
2014-08-25	2014-08-25	4	HNSN	HANSEN MEDICAL INC Series B/C Exchange Warrant	X - Other	-4,656,852	0	-100.00
2014-08-25	2014-08-25	4	HNSN	HANSEN MEDICAL INC Common Stock, par value $0.0001 per share	X - Other	652,724	2,566,946	34.10	1.13	737,578	2,900,649
2014-08-25	2014-08-25	4	HNSN	HANSEN MEDICAL INC Common Stock, par value $0.0001 per share	X - Other	1,171,866	4,608,579	34.10	1.13	1,324,209	5,207,694
2014-08-25	2014-08-25	4	HNSN	HANSEN MEDICAL INC Common Stock, par value $0.0001 per share	X - Other	4,656,852	18,313,858	34.10	1.13	5,262,243	20,694,660
2014-08-12	2014-08-11	4	HNSN	HANSEN MEDICAL INC Series D Warrant	J - Other	200,712	200,712
2014-08-12	2014-08-11	4	HNSN	HANSEN MEDICAL INC Series D Warrant	J - Other	360,350	360,350
2014-08-12	2014-08-11	4	HNSN	HANSEN MEDICAL INC Series D Warrant	J - Other	1,431,983	1,431,983
2014-08-12	2014-08-11	4	HNSN	HANSEN MEDICAL INC Series B/C Exchange Warrant	J - Other	652,724	652,724
2014-08-12	2014-08-11	4	HNSN	HANSEN MEDICAL INC Series B/C Exchange Warrant	J - Other	1,171,866	1,171,866
2014-08-12	2014-08-11	4	HNSN	HANSEN MEDICAL INC Series B/C Exchange Warrant	J - Other	4,656,852	4,656,852
2014-08-12	2014-08-11	4	HNSN	HANSEN MEDICAL INC Series B Warrant	J - Other	-326,362	0	-100.00
2014-08-12	2014-08-11	4	HNSN	HANSEN MEDICAL INC Series C Warrant	J - Other	-326,362	0	-100.00
2014-08-12	2014-08-11	4	HNSN	HANSEN MEDICAL INC Series B Warrant	J - Other	-585,933	0	-100.00
2014-08-12	2014-08-11	4	HNSN	HANSEN MEDICAL INC Series C Warrant	J - Other	-585,933	0	-100.00
2014-08-12	2014-08-11	4	HNSN	HANSEN MEDICAL INC Series B Warrant	J - Other	-2,382,426	0	-100.00
2014-08-12	2014-08-11	4	HNSN	HANSEN MEDICAL INC Series C Warrant	J - Other	-2,382,426	0	-100.00
2014-02-18	2014-02-14	4	HNSN	HANSEN MEDICAL INC Series A Warrant	X - Other	-326,362	0	-100.00
2014-02-18	2014-02-14	4	HNSN	HANSEN MEDICAL INC Series A Warrant	X - Other	-585,933	0	-100.00
2014-02-18	2014-02-14	4	HNSN	HANSEN MEDICAL INC Series A Warrant	X - Other	-2,328,426	0	-100.00
2014-02-18	2014-02-14	4	HNSN	HANSEN MEDICAL INC Common Stock, par value $0.0001 per share	X - Other	326,362	1,914,222	20.55	1.23	401,425	2,354,493
2014-02-18	2014-02-14	4	HNSN	HANSEN MEDICAL INC Common Stock, par value $0.0001 per share	X - Other	585,933	3,436,713	20.55	1.23	720,698	4,227,157
2014-02-18	2014-02-14	4	HNSN	HANSEN MEDICAL INC Common Stock, par value $0.0001 per share	X - Other	2,328,426	13,657,006	20.55	1.23	2,863,964	16,798,117
2013-12-23	2013-12-19	4	VRML	VERMILLION, INC. Warrants to acquire Common Stock	C - Conversion	-4,339,980	0	-100.00
2013-12-23	2013-12-19	4	VRML	VERMILLION, INC. Common Stock, par value $0.001 per share	C - Conversion	4,339,980	7,139,960	155.00
2013-08-08	2013-08-08	4	HNSN	HANSEN MEDICAL INC Series A Warrant	P - Purchase	326,362	326,362		0.12	40,795	40,795
2013-08-08	2013-08-08	4	HNSN	HANSEN MEDICAL INC Series C Warrant	P - Purchase	326,362	326,362		0.12	40,795	40,795
2013-08-08	2013-08-08	4	HNSN	HANSEN MEDICAL INC Series A Warrant	P - Purchase	585,933	585,933		0.12	73,242	73,242
2013-08-08	2013-08-08	4	HNSN	HANSEN MEDICAL INC Series C Warrant	P - Purchase	585,933	585,933		0.12	73,242	73,242
2013-08-08	2013-08-08	4	HNSN	HANSEN MEDICAL INC Series A Warrant	P - Purchase	2,328,426	2,328,426		0.12	291,053	291,053
2013-08-08	2013-08-08	4	HNSN	HANSEN MEDICAL INC Series C Warrant	P - Purchase	2,328,426	2,328,426		0.12	291,053	291,053
2013-08-08	2013-08-08	4	HNSN	HANSEN MEDICAL INC Series B Warrant	P - Purchase	326,362	326,362		0.12	40,795	40,795
2013-08-08	2013-08-08	4	HNSN	HANSEN MEDICAL INC Series B Warrant	P - Purchase	585,933	585,933		0.12	73,242	73,242
2013-08-08	2013-08-08	4	HNSN	HANSEN MEDICAL INC Series B Warrant	P - Purchase	2,328,426	2,328,426		0.12	291,053	291,053
2013-08-08	2013-08-08	4	HNSN	HANSEN MEDICAL INC Common Stock, par value$0.0001 per share	P - Purchase	815,904	1,587,860	105.69	1.23	1,003,562	1,953,068
2013-08-08	2013-08-08	4	HNSN	HANSEN MEDICAL INC Common Stock, par value$0.0001 per share	P - Purchase	1,464,842	2,850,780	105.69	1.23	1,801,756	3,506,459
2013-08-08	2013-08-08	4	HNSN	HANSEN MEDICAL INC Common Stock, par value$0.0001 per share	P - Purchase	5,821,064	11,328,580	105.69	1.23	7,159,909	13,934,153
2013-05-23		3	VRML	VERMILLION, INC. Common Stock, par value $0.001			2,799,980
2008-06-10	2008-03-11	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock Purchase Warrants	S - Sale	119,811	119,811
2008-06-10	2008-03-11	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock Purchase Warrants	P - Purchase	119,811	119,811
2008-06-10	2008-03-11	4	ACCP	ACCESS PHARMACEUTICALS INC Series A Cumulative Convertible Preferred Stock	S - Sale	72	72
2008-06-10	2008-03-11	4	ACCP	ACCESS PHARMACEUTICALS INC Series A Cumulative Convertible Preferred Stock	P - Purchase	72	72
2008-06-10	2008-02-12	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock	S - Sale	-29,736	296,483	-9.12	3.15	-93,668	933,921
2008-06-10	2008-02-12	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock	P - Purchase	29,736	296,483	11.15	3.15	93,668	933,921
2008-06-10	2007-11-10	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock Purchase Warrants	J - Other	728,850	728,850
2008-06-10	2007-11-10	4	ACCP	ACCESS PHARMACEUTICALS INC Series A Cumulative Convertible Preferred Stock	J - Other	437	437
2008-06-10	2007-07-24	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock	S - Sale	-2,040	296,483	-0.68	4.35	-8,874	1,289,701
2008-06-10	2007-07-23	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock	S - Sale	-4,000	298,523	-1.32	4.36	-17,425	1,300,456
2008-06-10	2007-06-19	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock	P - Purchase	60,000	302,523	24.74	5.17	310,200	1,564,044
2008-06-10	2007-06-19	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock	S - Sale	-20,000	302,523	-6.20	5.17	-103,400	1,564,044
2008-06-10	2007-06-19	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock	S - Sale	-40,000	302,523	-11.68	5.17	-206,800	1,564,044
2008-06-10	2007-03-01	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock	S - Sale	-1,200	302,523	-0.40	7.12	-8,550	2,155,476
2008-06-10	2007-02-28	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock	S - Sale	-4,500	302,523	-1.47	7.10	-31,950	2,147,913
2008-06-10	2007-02-28	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock	S - Sale	-10,000	302,523	-3.20	7.10	-71,000	2,147,913
2008-06-10	2007-02-27	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock	S - Sale	-100	318,223	-0.03	7.00	-700	2,227,561
2008-06-10	2007-02-27	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock	S - Sale	-300	318,223	-0.09	7.00	-2,100	2,227,561
2008-06-10	2007-02-26	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock	S - Sale	-1,000	318,623	-0.31	7.31	-7,314	2,330,409
2008-06-10	2007-02-26	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock	S - Sale	-5,000	318,623	-1.55	7.31	-36,570	2,330,409
2008-06-10	2007-02-26	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock	S - Sale	-19,000	318,623	-5.63	7.31	-138,966	2,330,409
2008-06-10	2007-01-22	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock	P - Purchase	6,040	343,623	1.79	2.53	15,281	869,366
2008-06-10	2007-01-22	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock	S - Sale	-6,040	343,623	-1.73	2.53	-15,281	869,366
2008-06-10	2006-09-01	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock	S - Sale	-0	343,623	0.00
2008-06-10	2006-09-01	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock	S - Sale	-0	343,623	0.00
2008-06-10	2006-09-01	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock	S - Sale	-1	343,623	0.00
2008-06-10	2006-06-05	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock	J - Other	-1,374,497	343,624	-80.00
2008-06-10	2005-12-31	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock	P - Purchase	78,184	1,718,121	4.77	0.65	50,820	1,116,779
2008-06-10	2005-12-31	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock	P - Purchase	299,056	1,718,121	21.07	0.65	194,386	1,116,779
2008-06-10	2005-12-31	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock	P - Purchase	82,745	1,718,121	5.06	0.65	53,784	1,116,779
2008-06-10	2005-12-31	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock	P - Purchase	15,636	1,718,121	0.92	0.65	10,163	1,116,779
2008-06-10	2005-02-01	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock	S - Sale	-30,200	1,242,500	-2.37	2.69	-81,238	3,342,325
2008-06-10	2005-02-01	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock, par value $0.01 per share ("Common Stock")	P - Purchase	30,200	1,242,500	2.49	2.69	81,238	3,342,325
2008-06-10		3	ACCP	ACCESS PHARMACEUTICALS INC Common Stock, par value $0.01 per share ("Common Stock")			900,400